The effect of statins on microalbuminuria, proteinuria, progression of kidney function, and all-cause mortality in patients with non-end stage chronic kidney disease: A meta-analysis
- 1 March 2016
- journal article
- research article
- Published by Elsevier BV in Pharmacological Research
- Vol. 105, 74-83
- https://doi.org/10.1016/j.phrs.2016.01.005
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Effect of atorvastatin on kidney function in chronic kidney disease: A randomised double-blind placebo-controlled trialAtherosclerosis, 2010
- Progression of Kidney Disease in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin Versus Usual Care: A Report From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)American Journal of Kidney Diseases, 2008
- Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsBMJ, 2008
- Effects of Statins on Renal FunctionMayo Clinic Proceedings, 2007
- Simvastatin for Secondary Prevention of All-Cause Mortality and Major Coronary Events in Patients With Mild Chronic Renal InsufficiencyAmerican Journal of Kidney Diseases, 2007
- Effect of Rosuvastatin on C-Reactive Protein and Renal Function in Patients With Chronic Kidney DiseaseThe American Journal of Cardiology, 2005
- Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy)The American Journal of Cardiology, 2005
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986